All filters
Abstracts
Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapy
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Slidesets
Next Generation Broadly Neutralizing Monoclonals - Lucio Gama, PhD
Presented at:
International Workshop on HIV Transmission 2021
Slidesets
STI Prevention by Doxycycline - Jean Michel Molina, MD, PhD
Presented at:
International Workshop on HIV Transmission 2021
Slidesets
Long-acting Lenacapavir for HIV Prevention - Moupali Das
Presented at:
International Workshop on HIV Transmission 2021
Slidesets
Complications of Acute COVID-19 - Otavio Berwanger, MD, PhD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
HIV in Persons Who Inject Drugs - Dita Broz, PhD, MPH
Presented at:
International Workshop on HIV Transmission 2021
Slidesets
Respiratory Management of COVID-19 - Vikram Mukherjee, MD, FRCP(Edin)
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Pediatric Manifestations of COVID-19 - Jeffrey Vergales, MD, MS
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Long COVID (Post-Acute COVID-19 Syndrome) - Susan Swindels, MBBS
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Immunomodulating Therapies - Karine Lacombe, MD, PhD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Monoclonal Antibodies for SARS-CoV-2 - Katharine Bar, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
SARS-CoV-2 Variants and Disease Severity - Robert Shafer, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
COVID-19 Therapeutics: State-Of-The-Art - Daniel Kuritzkes, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
STOPS Agents - M. McClure, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Antisense Oligos - L. Felton, Bsc, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Core Inhibitors (Capsid Assembly Modulators) - Luisa Stamm, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Biological Insights Taught by Clinical Responses to Novel Hbv-Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
How to Handle Flares in HBV Trials With Novel Agents - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021